Full Text View
Tabular View
No Study Results Posted
Related Studies
Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation
This study has been completed.
Study NCT01401478   Information provided by AbbVie

First Received on July 22, 2011.   Last Updated on February 20, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Secondary Hyperparathyroidism
Additional conditions recognized in this trial
Hyperparathyroidism
Hyperparathyroidism, Secondary
Kidney Diseases
Kidney Failure, Chronic
Parathyroid Diseases
Renal Insufficiency, Chronic
More general conditions related to this trial
Endocrine System Diseases
Renal Insufficiency
Urologic Diseases
Sponsors listed in this trial
AbbVie (prior sponsor, Abbott)
Almedis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services